Neurocrine Biosciences, Inc. (NBIX)
129.78
+2.00
(+1.57%)
USD |
NASDAQ |
Mar 13, 16:00
129.69
-0.09
(-0.07%)
After-Hours: 20:00
Neurocrine Biosciences Total Assets (Quarterly) : 4.753B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Glaukos Corp. | 930.37M |
| Edgewise Therapeutics, Inc. | 552.60M |
| Nuvalent, Inc. | 1.413B |
| Marker Therapeutics, Inc. | 21.73M |
| Agenus, Inc. | 233.89M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.500B |
| Shareholders Equity (Quarterly) | 3.253B |
| Debt to Equity Ratio | 0.1449 |
| Current Ratio | 3.394 |
| Net Debt Paydown Yield | -0.26% |